Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1613 1615 1722 1752 1795 3785
This examiner grants 69% of resolved cases
Sin J Lee, in Tech Center 3700 and Art Unit 1613, has handled 1062 resolved cases. The allowance rate is 68.8 percent, which is a solid majority of cases. The interview lift is 25.4 percent, suggesting that interviews are highly effective in this docket.
The median days to allowance is 1026. This timeline is based on the 1062 resolved cases. The 68.8 percent allowance rate indicates a generally positive outlook for applicants, which is further enhanced by the 25.4 percent interview lift.
Practitioners should consider the 1026 median days to allowance when scheduling. The interview lift is a significant advantage for those who choose to interview. In Art Unit 1613, the resolved cases provide a reliable indicator of the examiner's typical outcome. This data suggests that proactive communication is a valuable strategy for applicants.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18028937 | CANNABIS PLANT DERIVED EXTRACELLULAR VESICLES AND THERAPEUTIC METHODS USING THE SAME | Final Rejection | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 19544595 | FORMULATIONS OF VIMSELTINIB | Final Rejection | Deciphera Pharmaceuticals, LLC |
| 17762448 | HYPOCHLORITE COMPOSITION AND SYSTEM AND METHOD FOR PREPARING A HYPOCHLORITE COMPOSITION AND USE OF THE SAME | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18289733 | THERMOREVERSIBLE POLYMERS AND METHODS OF USE THEREOF | Final Rejection | The Regents of the University of California |
| 17082929 | 5HT AGONISTS FOR TREATING DISORDERS | Final Rejection | The Regents of the University of California |
| 18827625 | STORAGE STABLE MIXTURES | Non-Final OA | DSM IP Assets B.V. |
| 19104171 | INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS | Non-Final OA | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. |
| 18870008 | COSMETIC HAIR TREATMENT PROCESS, COMPRISING A WASHING STEP, A STEP OF APPLYING A COSMETIC COMPOSITION COMPRISING AMINO ACIDS AND HYDROXYLATED (POLY)CARBOXYLIC ACIDS, AND THEN A CONDITIONING STEP | Non-Final OA | L'OREAL |
| 18906267 | Compositions Containing Trihydroxystearin and Oil For Inhibiting Trihydroxystearin Crystallization | Non-Final OA | L'OREAL |
| 18825795 | AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA | Non-Final OA | PFIZER INC. |
| 19028247 | COMPLEXES FOR TREATING SENSITIVITY | Non-Final OA | THE UNIVERSITY OF MELBOURNE |
| 18833519 | NIRAPARIB AND ABIRATERONE ACETATE PLUS PREDNISONE TO IMPROVE CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND HRR ALTERATIONS | Non-Final OA | JANSSEN PHARMACEUTICA NV |
| 17908035 | COATED SPONGES | Non-Final OA | Dow Silicones Corporation |
| 18028058 | PHARMACEUTICAL FORMULATION | Non-Final OA | Agios Pharmaceuticals, Inc. |
| 17997499 | IONIC LIQUID AS AN ANTIPERSPIRANT | Final Rejection | Novigo GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy